Recurrent and persistent hematuria with diffuse endocapillary proliferative glomerulonephritis
ICD-10 N02.4 is a billable code used to indicate a diagnosis of recurrent and persistent hematuria with diffuse endocapillary proliferative glomerulonephritis.
N02.4 refers to a condition characterized by recurrent and persistent hematuria, which is the presence of blood in the urine, associated with diffuse endocapillary proliferative glomerulonephritis (GN). This type of GN is marked by an increase in the number of cells within the capillary loops of the glomeruli, leading to inflammation and damage. Patients typically present with symptoms such as hematuria, proteinuria, and possible edema. The condition can be secondary to infections, autoimmune diseases, or other underlying health issues. Diagnosis often involves renal biopsy, which may reveal hypercellularity, mesangial proliferation, and immune complex deposition. Management may include corticosteroids, immunosuppressive agents, and supportive care to control symptoms and prevent progression to chronic kidney disease. Regular monitoring of renal function and urine analysis is essential for assessing disease activity and treatment efficacy.
Detailed clinical notes on hematuria, renal function tests, and biopsy results.
Patients presenting with hematuria, proteinuria, and renal impairment.
Ensure all laboratory results and imaging studies are included in the documentation.
Comprehensive reports on renal biopsy findings and histological analysis.
Evaluation of renal biopsies for glomerular diseases.
Pathology reports must correlate with clinical findings for accurate coding.
Used when a renal biopsy is performed to confirm glomerulonephritis.
Document indication for biopsy and findings.
Nephrologists must ensure that the biopsy results correlate with clinical findings.
It indicates a specific type of glomerular inflammation that can lead to significant renal impairment if not managed properly.
